The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields
Iyad Y. Natsheh, Majd M. Alsaleh, Ahmad Khalaf Alkhawaldeh, Duaa K. Albadawi, Maisa’ M. Darwish, Mohammad Jamal A. Shammout
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.33393/dti.2024.3019 ↗
- Volume · Issue · Pages
- 18 · 1 · 8-19
- Publisher
- AboutScience Srl
- Article URL
- https://doi.org/10.33393/dti.2024.3019 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
02 May 2024
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 02 May 2024 | OpenAlex |
Keywords (as given): drug repurposing; clinical trial challenges; antimicrobial resistance; cardiovascular disease; cancer; diabetes mellitus; off-label drug use; drug safety; cost-effectiveness
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
X
Based on the recorded HEC dataset applicable to the article's publication date. Listed as X in the HEC list for 2023–24.
- Journal
- Drug Target Insights
- Publication date used
- 02 May 2024 (OpenAlex publication date)
- Applicable HEC period
- 2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
- Category
- X
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- HJRS 2023-24 page 1774, row 12549
- Verification status
- Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.